Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pandemic influenza A(H1N1)pdm09 seroprevalence in Sweden before and after the pandemic and the vaccination campaign in 2009.
Mörner A, Bråve A, Kling AM, Kühlmann-Berenzon S, Krook K, Hedenskog M, Silhammar I, Ljungman M, Ortqvist A, Andersson S, Brytting M, Thorstensson R, Linde A. Mörner A, et al. Among authors: brave a. PLoS One. 2012;7(12):e53511. doi: 10.1371/journal.pone.0053511. Epub 2012 Dec 28. PLoS One. 2012. PMID: 23285299 Free PMC article.
Seroprevalence of SARS-CoV-2 in Sweden, April 26 to May 9, 2021.
Beser J, Galanis I, Enkirch T, Kühlmann Berenzon S, van Straten E, Duracz J, Rapp M, Zakikhany K, Mansjö M, Wigren Byström J, Forsell MNE, Groenheit R, Tegmark Wisell K, Bråve A. Beser J, et al. Among authors: brave a. Sci Rep. 2022 Jun 25;12(1):10816. doi: 10.1038/s41598-022-15183-w. Sci Rep. 2022. PMID: 35752708 Free PMC article.
Point prevalence of SARS-CoV-2 infection in Sweden at six time points during 2020.
Groenheit R, Beser J, Kühlmann Berenzon S, Galanis I, van Straten E, Duracz J, Rapp M, Hansson D, Mansjö M, Söderholm S, Muradrasoli S, Risberg A, Ölund R, Wiklund A, Metzkes K, Lundberg M, Bacchus P, Tegmark Wisell K, Bråve A. Groenheit R, et al. Among authors: brave a. BMC Infect Dis. 2022 Nov 17;22(1):861. doi: 10.1186/s12879-022-07858-6. BMC Infect Dis. 2022. PMID: 36396981 Free PMC article.
Evaluation of immunogenicity and efficacy of combined DNA and adjuvanted protein vaccination in a human immunodeficiency virus type 1/murine leukemia virus pseudotype challenge model.
Rollman E, Mathy N, Bråve A, Boberg A, Kjerrström A, van Wely C, Engström G, Johansson S, Aperia K, Eriksson LE, Benthin R, Ertl P, Heeney J, Hinkula J, Voss G, Wahren B. Rollman E, et al. Among authors: brave a. Vaccine. 2007 Mar 1;25(11):2145-54. doi: 10.1016/j.vaccine.2006.10.057. Epub 2006 Nov 13. Vaccine. 2007. PMID: 17254672
Murine models for HIV vaccination and challenge.
Boberg A, Bråve A, Johansson S, Wahren B, Hinkula J, Rollman E. Boberg A, et al. Among authors: brave a. Expert Rev Vaccines. 2008 Feb;7(1):117-30. doi: 10.1586/14760584.7.1.117. Expert Rev Vaccines. 2008. PMID: 18251698 Review.
Broad and potent cellular and humoral immune responses after a second late HIV-modified vaccinia virus ankara vaccination in HIV-DNA-primed and HIV-modified vaccinia virus Ankara-boosted Swedish vaccinees.
Nilsson C, Godoy-Ramirez K, Hejdeman B, Bråve A, Gudmundsdotter L, Hallengärd D, Currier JR, Wieczorek L, Hasselrot K, Earl PL, Polonis VR, Marovich MA, Robb ML, Sandström E, Wahren B, Biberfeld G. Nilsson C, et al. Among authors: brave a. AIDS Res Hum Retroviruses. 2014 Mar;30(3):299-311. doi: 10.1089/AID.2013.0149. Epub 2013 Nov 15. AIDS Res Hum Retroviruses. 2014. PMID: 24090081 Free PMC article. Clinical Trial.
A new multi-clade DNA prime/recombinant MVA boost vaccine induces broad and high levels of HIV-1-specific CD8(+) T-cell and humoral responses in mice.
Bråve A, Boberg A, Gudmundsdotter L, Rollman E, Hallermalm K, Ljungberg K, Blomberg P, Stout R, Paulie S, Sandström E, Biberfeld G, Earl P, Moss B, Cox JH, Wahren B. Bråve A, et al. Mol Ther. 2007 Sep;15(9):1724-33. doi: 10.1038/sj.mt.6300235. Epub 2007 Jun 19. Mol Ther. 2007. PMID: 17579577 Free article.
59 results